ID: ALA3092533

Max Phase: Preclinical

Molecular Formula: C25H23N3O2

Molecular Weight: 397.48

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C(CCCc1nc2ccccc2c(=O)[nH]1)NC(c1ccccc1)c1ccccc1

Standard InChI:  InChI=1S/C25H23N3O2/c29-23(17-9-16-22-26-21-15-8-7-14-20(21)25(30)27-22)28-24(18-10-3-1-4-11-18)19-12-5-2-6-13-19/h1-8,10-15,24H,9,16-17H2,(H,28,29)(H,26,27,30)

Standard InChI Key:  YROHEJVXYKKJCO-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 397.48

Molecular Weight (Monoisotopic): 397.1790

AlogP: 4.15

#Rotatable Bonds: 7

Polar Surface Area: 74.85

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 9.95

CX Basic pKa: 5.87

CX LogP: 3.97

CX LogD: 4.01

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.49

Np Likeness Score: -1.09

References

1. Lindgren AE, Karlberg T, Ekblad T, Spjut S, Thorsell AG, Andersson CD, Nhan TT, Hellsten V, Weigelt J, Linusson A, Schüler H, Elofsson M..  (2013)  Chemical probes to study ADP-ribosylation: synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3/PARP3.,  56  (23): [PMID:24188023] [10.1021/jm401394u]

Source

Source(1):

• Scientific Literature